Objective: We aimed to delineate the distribution of periventricular nodular heterotopia (PNH) in patients with 22q11.2 microdeletion syndrome (22q11.2DS) and place this in the context of other genetic forms of PNH. Methods: We retrospectively analyzed brain imaging and postmortem data available for adult patients with 22q11.2DS. We included only those with good quality MRI data (n = 29) in addition to two patients with PNH identified through postmortem studies. We also reviewed the pattern of PNH in all genetic conditions reported with this phenotype. Results: Of the total seven patients (M = 4, F = 3; age: 19-61 years) identified to have PNH, six had a history of seizures, six had schizophrenia, six had variable levels of intellectual disability, and two had obsessive compulsive disorder. In all seven patients, the nodules were located over the dorsal pole of the frontal horn of the lateral ventricles. The nodules were small, noncontiguous, and ranged in number from 1 to 10 per individual. Our review identified 37 genetic conditions associated with PNH. With the cases reported here, 22q11.2DS becomes the fifth most commonly reported genetic condition, and the third most common copy number variation, associated with PNH. Interpretation: The neuropsychiatric manifestations in our patients with PNH support other data indicating abnormal neurodevelopment as part of the pathogenesis of 22q11.2DS.The location and cellular characteristics of PNH in 22q11.2DS overlaps with a group of migrating postnatal interneurons termed Arc cells, although more research is needed to confirm that PNH in 22q11.2DS represents Arc cells arrested in their migratory pathway.
Introduction
22q11.2 microdeletion syndrome (22q11.2DS), which encompasses conditions formerly known as velocardiofacial syndrome or DiGeorge syndrome, is the most common pathogenic copy number variation (CNV) in humans, affecting about 1 in 4000 people. 1 In adults with 22q11.2DS neuropsychiatric disorders such as intellectual disability, seizures and schizophrenia are a significant cause of morbidity. [2] [3] [4] The prevalence of recurrent seizure disorder in adults with 22q11.2DS is estimated to be about 11%. 4 Seizures may be triggered by hypocalcemia, fever, and/or antipsychotic medications. Epilepsy is reported in patients with epileptogenic structural brain abnormalities, such as periventricular nodular heterotopia (PNH), polymicrogyria, etc. In many cases, however, no additional risk factors can be identified, and the unprovoked, recurrent seizures are thought to result from genetic generalized epilepsy or focal epilepsy. [4] [5] [6] [7] Schizophrenia is seen in up to 25% of 22q11.2DS patients. 8 Comprising up to 1% of all schizophrenia patients, 22q11.2DS is the most common detectable genetic cause of schizophrenia. 9 The pathophysiological mechanisms leading to schizophrenia are believed to be related to abnormal neural development. 10 Identifying PNH in the first postmortem pathology of a patient with 22q11.2DS 11 prompted us to study the presence of these lesions through high-resolution brain imaging. In the current, we set out to study the anatomical characteristics of PNH and explore its association with the neuropsychiatric manifestations of 22q11.2DS patients.
Methods Patients
Adult 22q11.2DS patients were recruited from the epilepsy genetics clinic at Toronto Western Hospital, University of Toronto, and were further screened for the presence of PNH. Of 35 patients who had brain MRI data, 6 were excluded due to poor quality images. We included two additional patients with 22q11.2DS, whose postmortem studies were previously reported by our team. 11, 12 Demographic and clinical features of the 31 patients were obtained from chart reviews and included age, sex, and comprehensive neuropsychiatric history. The diagnosis of 22q11.2DS for these patients was previously established by FISH or clinical microarray, and their consent for inclusion in the study was obtained as per research ethics board (REB) protocols at the University Health Network and/or Centre for Addiction and Mental Health.
Imaging
22q11.2DS patients underwent 3 Tesla brain MRI with a dedicated seizure protocol including high-resolution axial and coronal T1 IR and T2 FLAIR sequences as well as isotropic T1 FSPGR sequences with multiplanar reformats. 13 In addition, axial DWI and SWI-weighted sequences were obtained. Images were reviewed in consensus by a neuroradiologist specialized in epilepsy imaging (TK) and 2 neurologists (AR, DA).
Additional genetic studies
In addition to standard clinical features and the FISH confirmation of typical 22q11.2 deletion in all 7 patients, five patients also had whole genome sequencing (WGS) as part of another study. 14 The WGS data was used in this study only to determine if patients with PNH had other structural genomic rearrangements such as CNV or single nucleotide variant (SNV) previously associated with known causes of PNH. A sixth patient had genome-wide high-resolution research microarray.
Literature review
We used PubMed (January 1, 1993 to February 20, 2018) to review the literature regarding causes of PNH and its distribution, using the following terms: ((periventricular or ventricular or ventricle or ventricles) (nodular or nodule or nodules) (heterotopia or heterotopic)) AND (deletion or duplication or (copy number) or chromosomal or chromosome or syndrome or syndromic or syndromal or genetic or genomic or gene or mutation).
Results
Of the 29 alive patients ascertained with usable MRI data, five (17.2%) had PNH ( Fig. 1A-E) . Three of these 5 patients had been reported previously by our team. (patients 1, 2 and 4). 6 For one of the two patients in whom PNH was identified through autopsy, 11, 12 MRI data had previously been interpreted as normal; however, re-review of MRI after postmortem findings confirmed the diagnosis of PNH (Fig. 1F) . Of the seven patients with PNH studied, three were female. Intellectual disability (ID) was present in six, ranging from mild to severe. Six of these seven patients had a history of acute symptomatic seizures or epilepsy. In these, the median age of seizure onset was 12.5 years. The seizure types included generalized tonic clonic, myoclonic, and/or focal impaired awareness seizures. Six of the seven patients had a diagnosis of schizophrenia and two were diagnosed with obsessive-compulsive disorder (OCD) ( Table 1) .
The PNH nodules detected on MRI and autopsy were small, noncontiguous, and adjacent to the dorsal pole of the anterior (frontal) horn of the lateral ventricles (DPAHLV) in all seven cases (Fig 1A-F and 2A ). Nodules were unilateral in five patients and single in four patients (Table 1) . Patients with multiple nodules had no more than 10 nodules seen on MRI or macroscopically at autopsy. However, on both autopsy cases, several other small nodules were seen only microscopically. 11 For instance, patient 6 had multiple microscopic, spherical noncontiguous nodules, closely spaced around the larger macroscopic nodules (Fig. 2B ). In addition, there were "large numbers of individual cortical-type neurons found in the white matter of the frontal lobe between the heterotopic nodules and the nearest cortical surface" (Fig. 2C) . 11 The postmortem macroscopic study of patient 7 revealed several small, nodular heterotopia in the deep frontal white matter near the anterior horn of the lateral ventricle (Fig. 2D ). Immunohistochemistry studies showed these nodules were formed by mature neurons and GABAergic interneurons-expressing NeuN, calretinin, and synaptophysin ( Fig. 2D-F) . 12 WGS on patients 1, 2, 4, 6 and 7 did not reveal any other pathogenic SNVs or CNVs known to be associated with PNH Supplemental Table 1 ).
14 Genome-wide microarray in patient 3 also did not reveal additional CNVs, only the known 22q11.2 microdeletion. To place these 22q11.2DS findings in the context of the overall genetic etiology of PNH, we performed a literature review. Table S1 shows the genes and/or rare CNVs associated with PNH along with a brief description of anatomical distribution of PNH reported. As of February 2018, there were 37 genetic abnormalities associated with various patterns of PNH. The new patients reported here make 22q11.2 microdeletion the third most common CNV and the fifth most common genetic cause described in association with PNH. The details of other CNVs and the characteristics of the PNHs reported are listed in Table S1 .
Discussion

Genetics of PNH and its distribution
Although the number of patient is small, the PNH characteristics observed in our patients with 22q11.2DS were consistent: small nodules, noncontiguous, varying in number from 1 to 10, located over the dorsal pole of the anterior horn of the lateral ventricles (DPAHLV), uni-or bilaterally. Furthermore, microscopic nodules were present at the tip of the DPAHLV and more distantly along the deep frontal white matter, between the DPAHLV and the cortex in the frontal lobes.
PNH has been previously reported in three children with 22q11.2DS. 7, 15 The patient reported by Kim et al., had a single PNH over the DPAHLV. 7 The MRIs of the other 2 children demonstrated symmetrical bilateral PNH, lining the temporal horns of the lateral ventricles with limited extension into the frontal horns in one of the patients. 15 Although the PNH distribution in these two children may still be attributed to the 22q11.2 microdeletion, it is not clear whether these patients had other CNVs or SNVs in other genes that could have accounted for the difference in their distribution, since one of those patients was diagnosed through FISH and the other had a low-resolution array only. Five of our seven patients had WGS which ruled out the presence of mutations in any other genes previously known to be associated with PNH, as well as the presence of other pathogenic CNVs. No other CNV was detected in patient 3 as per high-resolution genome-wide chromosome microarray.
The literature review showed that the majority of patients with PNH and a known genetic cause have heterozygous filamin-A (FLNA) pathogenic variants. [16] [17] [18] [19] [20] [21] [22] [23] This is frequently (but not always) associated with the "classical bilateral PNH" pattern, where nodules are often large, multiple, contiguous, symmetric and abutting the walls of the ventricles. They are distributed bilaterally, along the frontal horns and ventricular bodies, almost always sparing the temporal horns, or with minor temporal involvement, and limited extension into the posterior horns. 17, 20, 23 17q21.31 microdeletion represents the second most commonly reported genetic cause of PNH, with small, single, unilateral nodules. Autosomal recessive mutations in the ARFGEF2 gene represent the third most commonly reported genetic etiology of PNH with diffuse bilateral near-contiguous or contiguous pattern often associated with a microcephaly phenotype. [24] [25] [26] 6q27 deletion is the fourth most commonly reported cause of PNH with uni or bilateral nodules in the frontal and temporal horns of the lateral ventricles. With the cases reported here, 22q11.2 microdeletion is the fifth most common genetic cause and the third most common CNV reported in association with PNH (see Table S1 ). PNH in 22q11.2DS might result from arrested "Arc" migrating cells
Although this study was not designed to determine the origin of PNH in 22q11.2 microdeletion, a remarkable overlap with a recently described population of late migrating neurons called "Arc cells" 27 was observed. Therefore, we briefly discuss the hypothesis that PNH in 22q11.2DS may result from arrested migration of these cells.
In postnatal infant human brain an "Arc" of migrating cells moves away from the subventricular zone (SVZ) around the DPAHLV towards the anterior cingulate gyrus and prefrontal cortex (Fig. 3) . The migrating neuroblasts are organized in chains or individual cells. In brains studied from 34 gestational weeks to 7 months of life, the neuronal migration process is divided into four tiers with different cell concentrations in different regions at different times. Tier 1 neurons are densely packed in the SVZ around the DPAHLV walls. Tiers 2 and 3 have clusters of neurons that are progressively more distant from the ventricles. Tier 4 neurons are dispersed within areas of the developing white matter, closer to the cortex. 27 Given the reported distribution of cells in this Arc, it is possible that in our population of 22q11.2DS patients, the larger PNHs observed on MRI maybe neurons whose migration was arrested in the Arc tiers 1 or 2, while the microscopic nodules and individual neurons observed in the autopsy cases are representative of neurons in the Arc tiers 3 and 4. In addition to the anatomical overlap, both Arc cells and 22q11.2DS neurons studied at autopsy express GABA and calretinin. 11, 12, 27 Finally, Arc cells express CXCR4 receptor, a marker of migrating interneurons. 27 Interestingly, 22q11.2 deletion leads to a significant decrease in the expression of Cxcr4, 28 suggesting that 22q11.2 haploinsufficiency could have a role in the abnormal migration of Arc cells. The Arc is the only migratory pathway described so far that appears to overlap with the PNH findings in patients with 22q.11.2DS. The other group of cells which migrate from the anterior horn of the lateral ventricles, leaves the SVZ through the floor of the ventricles (the "rostral migratory stream" (RMS)). 29 Therefore, the arrested migration of RMS cells would be expected to produce PNH around the ventral pole of the anterior horn of the lateral ventricles.
Supporting the hypothesis that PNH is caused by 22q11.2 microdeletion is the fact that six genes located in the 22q11.2 deletion region are relevant for corticogenesis: Cdc45 l and Ranbp1 genes are "specifically and robustly" expressed in VZ/SVZ. Htf9c and Ufd1 l genes are expressed in the VZ/SVZ but also in the developing cortical plate; Hira is weakly distributed throughout the developing cortex and Sept5 is present in the developing cortical plate and absent in the VZ/SVZ. 30 Neuropsychiatric symptoms, anatomical and molecular correlation
Although the large majority of patients with 22q11.2DS have the same 3 Mb deletion, not all patients manifest all the phenotypes associated to this syndrome. This is likely due to the complex interplay between the hemizygous deletion, the reminder of the patient's genome and to a certain degree, the environment.
Six out of the 7 patients described here had a clinical diagnosis of schizophrenia, 2 had OCD, 6 had ID, and 6 had seizures. Seizures could be a result of the PNH (which contains epileptogenic cells) 31 although patients with 22q11.2DS and no structural abnormalities also have an overall lower seizure threshold. 4 Schizophrenia, OCD and ID have been associated with multiple structural abnormalities, including abnormal cortical thickness and connectivity in the cingulate, prefrontal cortex, olfactory bulb, amongst other regions. [32] [33] [34] [35] [36] Postmortem studies of non-22q11.2DS schizophrenic brains have also shown decline in GABAergic interneurons most prominently in pre-frontal and cingulate association cortices. 37, 38 If the cells that form the PNH in our patients are derived from the Arc, and Arc cells were destined to cingulate and prefrontal cortex, it is plausible that adult patients with 22q11.2DS and PNH have fewer cells in those regions, which could contribute, at least in part, to their phenotype.
PNH and (possibly) arrested Arc cells migration are not the only mechanism of abnormal neurodevelopment that could underlie the neuropsychiatric manifestations in 22q11.2 patients, but they reflect a disturbed corticogenesis. For instance, 22q11.2DS has been associated with a postnatal generalized microcolumnar cerebral cortical architecture, 39 supporting the role of genes in 22q11.2 deletion interval in the process of maturation. Tbx1 gene, which is present in the typical 22q11.2 deletion interval, plays a significant role in prefrontal corticogenesis including migration of inhibitory cells of prefrontal and olfactory bulb from the ganglionic eminence (GE) through RMS. 40, 41 A Tbx1 haploinsufficiancy model caused thinner proliferating zones in the mediolateral cortex and GE. 41 Animal models of Ranbp1 (another gene in the typical 22q11.2 interval) loss of function show decreased size of GE, decreased proliferation of forebrain progenitor cells, thinned cortex (especially cortical layers 2 and 3) and decreased size of olfactory bulbs. 42 Interestingly, RANBP1 gene polymorphisms have been associated with schizophrenia vulnerability in non-22q11.2DS individuals. 43 There are some limitations to this study: Two of the seven patients did not have WGS (although one of these 2 had genome-wide high-resolution chromosomal microarray). This retrospective study was not designed to measure cortical thickness reported in 22q11.2DS imaging. 44 Furthermore, it is unclear if such a small number of cells that are retained in the PNH would lead to abnormal cortical thickness detectable by current imaging technology. Finally, this was a clinical study, and further experimental studies would be needed to evaluate any relationship between Arc cells migration and 22q11.2DS.
In conclusion, we describe the radiological and pathological characteristics of PNH in 7 adult patients with 22q11.2DS. The anatomical and immunohistochemical features of 22q11.2DS related-PNH, and additional surrounding microscopic heterotopic neurons found at autopsy suggest that this abnormality could result from arrested migration of Arc cells. Since Arc cells are mainly destined to the prefrontal cortex and anterior cingulate cortex, it is expected that these regions would have subtle cytoarchitectural and physiological abnormalities, which may contribute to the common neuropsychiatric features seen in 22q11.2DS such as epilepsy, schizophrenia, OCD, and ID.
